Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. Market Characterisitics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Devices
5.3. Disposables
6. Application: Market Size & Analysis
6.1. Overview
6.2. Plasmapheresis
6.3. Plateletpheresis
6.4. Erythrocytapheresis
6.5. Leukapheresis
6.6. Photopheresis

7. Technology: Market Size & Analysis
7.1. Overview
7.2. Membrane Filtration
7.3. Centrifugation
8. Method: Market Size & Analysis
8.1. Overview
8.2. Automated Blood Collection
8.3. Therapeutic Apheresis
9. Geography: Market Size & Analysis
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World
10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.3. Mergers and Acquisitions, Legal, Awards, Partnerships
10.4. Product Launches and execution
11. Vendor Profiles
11.1. Mallinckrodt Plc
11.1.1. Overview
11.1.2. Product Offerings
11.1.3. Geographic Revenue
11.1.4. Business Units
11.1.5. Developments
11.1.6. SWOT Analysis
11.1.7. Business Strategy
11.2. Medicap Clinic GmbH
11.2.1. Overview
11.2.2. Product Offerings
11.2.3. Geographic Revenue
11.2.4. Business Units
11.2.5. Developments
11.2.6. SWOT Analysis
11.2.7. Business Strategy

11.3. LMB Technologie GmbH
11.3.1. Overview
11.3.2. Product Offerings
11.3.3. Geographic Revenue
11.3.4. Business Units
11.3.5. Developments
11.3.6. SWOT Analysis
11.3.7. Business Strategy
11.4. Bioelettronica Srl
11.4.1. Overview
11.4.2. Product Offerings
11.4.3. Geographic Revenue
11.4.4. Business Units
11.4.5. Developments
11.4.6. SWOT Analysis
11.4.7. Business Strategy
11.5. Infomed
11.5.1. Overview
11.5.2. Product Offerings
11.5.3. Geographic Revenue
11.5.4. Business Units
11.5.5. Developments
11.5.6. SWOT Analysis
11.5.7. Business Strategy
11.6. B. Braun Melsungen AG
11.6.1. Overview
11.6.2. Product Offerings
11.6.3. Geographic Revenue
11.6.4. Business Units
11.6.5. Developments
11.6.6. SWOT Analysis
11.6.7. Business Strategy
11.7. Cerus Corporation
11.7.1. Overview
11.7.2. Product Offerings
11.7.3. Geographic Revenue
11.7.4. Business Units
11.7.5. Developments

11.7.6. SWOT Analysis
11.7.7. Business Strategy
11.8. Kaneka Corporation
11.8.1. Overview
11.8.2. Product Offerings
11.8.3. Geographic Revenue
11.8.4. Business Units
11.8.5. Developments
11.8.6. SWOT Analysis
11.8.7. Business Strategy
11.9. Kawasumi Laboratories, Inc.
11.9.1. Overview
11.9.2. Product Offerings
11.9.3. Geographic Revenue
11.9.4. Business Units
11.9.5. Developments
11.9.6. SWOT Analysis
11.9.7. Business Strategy
11.10. Nikkiso Co., Ltd.
11.10.1. Overview
11.10.2. Product Offerings
11.10.3. Geographic Revenue
11.10.4. Business Units
11.10.5. Developments
11.10.6. SWOT Analysis
11.10.7. Business Strategy

12. Companies to Watch
12.1. Macopharma SA
12.1.1. Overview
12.1.2. Market
12.1.3. Business Strategy
12.2. Miltenyi Biotec
12.2.1. Overview
12.2.2. Market
12.2.3. Business Strategy
12.3. Otsuka Holdings Co., Ltd.

12.3.1. Overview
12.3.2. Market
12.3.3. Business Strategy
12.4. Medica Spa
12.4.1. Overview
12.4.2. Market
12.4.3. Business Strategy
12.5. Cytosorbents Corporation
12.5.1. Overview
12.5.2. Market
12.5.3. Business Strategy
12.6. Toray Medical Co., Ltd.
12.6.1. Overview
12.6.2. Market
12.6.3. Business Strategy
12.7. Terumo BCT, Inc.
12.7.1. Overview
12.7.2. Market
12.7.3. Business Strategy
12.8. Fresenius Se & Co. KGaA
12.8.1. Overview
12.8.2. Market
12.8.3. Business Strategy
12.9. Haemonetics Corporation
12.9.1. Overview
12.9.2. Market
12.9.3. Business Strategy
12.10. Baxter International Inc.
12.10.1. Overview
12.10.2. Market
12.10.3. Business Strategy
12.11. Asahi Kasei Medical Co. Ltd
12.11.1. Overview
12.11.2. Market
12.11.3. Business Strategy

13. Analyst Opinion
14. Annexure
14.1. Report Scope
14.2. Market Definitions
14.3. Research Methodology
14.3.1. Data Collation and In-house Estimation
14.3.2. Market Triangulation
14.3.3. Forecasting
14.4. Report Assumptions
14.5. Declarations
14.6. Stakeholders
14.7. Abbreviations